ClinicalTrials.govpublic full text
HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC
hepatocellular carcinoma, hepatic arterial infusion chemotherapy, programmed cell death protein-1 antibody, oxaliplatin, 5-fluorouracil and leucovorin, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912416
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.